key: cord-0288846-p8zg00qd
authors: Issaian, Aaron; Hay, Ariel; Dzieciatkowska, Monika; Roberti, Domenico; Perrotta, Silverio; Darula, Zsuzsanna; Redzic, Jasmina; Busch, Micheal P.; Page, Grier P.; Hansen, Kirk C.; Eisenmesser, Elan Z; Zimring, James C; D’Alessandro, Angelo
title: The interactome of the N-terminus of band 3 regulates red blood cell metabolism and storage quality
date: 2020-11-30
journal: bioRxiv
DOI: 10.1101/2020.11.30.404756
sha: a3a78dd55848f694c1bb31443d1ae43229e37ba7
doc_id: 288846
cord_uid: p8zg00qd

Band 3 (anion exchanger 1 - AE1) is the most abundant membrane protein in red blood cells (RBCs), the most abundant cell in the human body. A compelling model, based on indirect evidence, posits that - at high oxygen saturation - the N-term cytosolic domain of AE1 binds to and inhibits glycolytic enzymes, thus diverting metabolic fluxes to the pentose phosphate pathway to generate reducing equivalents. Dysfunction of this mechanism occurs during RBC aging or storage under blood bank conditions, suggesting a role for AE1 in the regulation of blood storage quality and efficacy of transfusion – a life-saving intervention for millions of recipients worldwide. Here we leverage two murine models carrying genetic ablations of AE1 to provide the first direct mechanistic evidence of its role in metabolic regulation and blood storage quality. Observations in mice phenocopied those in a human subject lacking expression of AE11-11 (band 3 Neapolis), while common polymorphisms in the region coding for AE11-56 increased susceptibility to osmotic hemolysis in healthy blood donors. Through thermal proteome profiling and cross-linking proteomics, we provide the first comprehensive analysis of the RBC interactome, with a focus on AE11-56 and validate recombinant AE1 interactions with glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Finally, we show that incubation with a cell-penetrating AE11-56 peptide can rescue the metabolic defect in glutathione recycling and boost post-transfusion recoveries of stored RBCs from healthy human donors and genetically ablated mice, paving the way for the in vivo metabolic manipulation of RBCs facing oxidant stress – a landmark of many diseases. Key points Genetic ablation of N-term of band 3 results in significant metabolic aberrations and poor post-transfusion recoveries in mice and humans; Structural studies on the N-term of band 3 reveal a complex interactome with several enzymes, including GAPDH;

Band 3 -also known as anion exchanger 1 (AE1), owing to its role in the exchange of chloride for bicarbonate anions 1 -is one of the main targets of oxidant stress during red blood cell (RBC) aging in vivo and in the blood bank. 2,3 AE1 also regulates RBC metabolism to allow adaptation to hypoxia and oxidant stress 4 . The N-terminal cytosolic domain of AE1 serves as a docking site for deoxygenated-hemoglobin (Hb), with significantly higher affinity than oxygenated-Hb 5, 6 . Based on this evidence, it has been proposed that Hb, in addition to its central role of carrying O 2 from the lungs to peripheral tissues, may serve as the "oxygen sensor" that directs AE1 to regulate metabolism appropriately. Indeed, studies had provided compelling, yet indirect evidence, thatwhen not encumbered by deoxy-Hb -the N-term of AE1 can bind to and, in so doing, inhibit the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH). [7] [8] [9] [10] [11] Notably, RBCs host ~1 million copies of both AE1 and GAPDH. 4 A wealth of indirect evidence supports the likelihood and biological relevance of AE1-GAPDH interactions, based on data from immunofluorescencebased experiments, 7,8 enzymatic activity assays, metabolic flux analysis via NMR, 9 analytical ultracentrifugation 10 , in silico prediction, 11 and genetic ablation of the N-term of band 3 in mice. 12 However, early cross-linking studies have hitherto failed to produce direct evidence of the interaction of GAPDH with the N-term residues. 7 Still, a widely accepted model has been proposed, according to which AE1 serves as a "railway switch" diverting glucose down different tracks (glycolysis vs. Pentose Phosphate Pathway -PPP) depending upon cellular needs 8, 13, 14 . This model explains why -when oxidant stress is high and GAPDH is bound to AE1 and thereby inhibited -RBC favor glucose oxidation via the PPP, to generate the reducing cofactor NADPH and fuel related antioxidant systems; 15 on the other hand, RBCs would rely on glycolysis when oxidant stress is low (e.g., high altitude 16 ), Hb is deoxygenated and binds to the N-term of AE1, which in turn favors the release of glycolytic enzymes from the membrane to promote the generation of energy in the form of ATP and NADH. Regulating the balance between glycolysis and PPP is essential for RBCs to respond to their particular metabolic needs (membrane pump function, cytoskeleton and lipid homeostasis), which are a function of whether the RBCs are exposed to high or low oxygen tensions in the lungs or peripheral capillaries. 17 We and others have proposed that this mechanism may be dysregulated as RBCs age and/or become damaged as a result of pathology or iatrogenic intervention (e.g., blood storage) 18, 19 , depriving RBCs of critical metabolic plasticity and leading to their demise 3 . So far, the role of AE1

in RBC storage quality has only been hypothesized, based on a body of evidence that includes (i) an increase in AE1 fragmentation as a function of oxidant stress in stored RBCs; [20] [21] [22] [23] [24] (ii) a progressive loss of the capacity to activate the PPP in stored RBCs, [25] [26] [27] despite the gradual inhibition of GAPDH as a function of its oxidation at the active site Cys152 and 156, His179; 28 (iii) an increase in band 3 phosphorylation at Y residues as a function of storage, 29 which correlates to the release of microparticles from stored RBCs; (iv) disruption of GAPDH localization in the membrane upon phosphorylation of Y8 and 21 of AE1; 1, 11, 30 (v) a poorer storage quality and post-transfusion recovery (PTR) of RBCs from donors who are incapable of activating the PPP because of deficient glucose 6-phosphate dehydrogenase (G6PD) activity; 31, 32 (vi) changes in AE1 oligomeric structure correlate with the loss of phospholipid asymmetry in stored RBCs, which could impact survival upon transfusion. 3, 33 Despite this evidence, the role of AE1 in blood storage quality has not yet been elucidated mechanistically.

Animal studies with mice All the animal studies described in this manuscript were reviewed and approved by the University of Virginia Institutional Animal Care and Use Committee (protocol n: 4269). Band 3 mouse founders, including huB3, HA Del and BS KO mice -originally generated by Chu et al. 34 -were acquired from the National Institutes of Health mouse embryo repository and were bred with C57BL/6 females. The use of Ubi-GFP and HOD mice have been previously described in prior work from our group. 35 Whole blood was drawn by cardiac puncture as a terminal procedure for the mice.

RBCs (100 ul) were obtained from a subject carrying a mutation resulting in the lack of AE1 amino acids 1-11, as extensively described by Perrotta et al. 30 REDS-III RBC Omics study Details about patient enrollment, blood processing, osmotic hemolysis and development of the transfusion medicine genome wide genotyping array have been described extensively in prior studies on the background of the project. 32, 36, 37 Methylene blue treatments RBCs from WT and band 3 KO mice were incubated with methylene blue (100 uM, Sigma Aldrich) at 37°C for 1h, as described. 31 Storage under blood bank conditions RBCs from the four main strains investigated in this study, along with 13 different mouse strains described before 38 were collected, processed, stored, transfused and post-transfusion recovery was determined as previously described. 38 Tracing experiments with labeled glucose, citrate, glutamine, arachidonic acid and methionine RBCs from all the mouse strains investigated in this study (100 ul) or RBC lysates from healthy donor volunteers (n=3) or the individual carrying band 3 Neapolis RBCs were incubated at 37ºC for 1h in presence of stable isotope-labeled substrates, as described previously. 22 Metabolomics analyses were performed using a Vanquish UHPLC coupled online to a Q Exactive mass spectrometer (Thermo Fisher, Bremen, Germany), as described previously. 39, 40 Proteomics Proteomics analyses, Thermal proteome profiling (TPP) and cross-linking experiments were performed via FASP digestion and nanoUHPLC-MS/MS identification (Thermo Fisher), as previously described. 41 15 N-heteronuclear single quantum coherence (HSQC) spectra were collected at 25ºC for the recombinantly expressed band 3 peptide 1-56 in the presence of 100 and 200 uM GAPDH. Data were collected on a Varian 900 using a standard 15 N-HSQC sequence.

Despite similar function, the amino acid sequence is poorly conserved between mice and humans at the N-term 6 ( Fig.1.A) . As such, Low's group generated a knock-in mouse by inserting the human binding site (amino acids ) into the mouse AE1, resulting in a human-mouse hybrid AE1 (HuB3) that could be used for a reductionist analysis of the human binding motif 5 . Two additional mouse models were subsequently made: (i) the first one, carries a deletion of the first 11 amino acid residues -hereon referred to as high affinity deletion or HA Del, since deletion of these residues negatively impacts binding of glycolytic enzymes, as suggested by immunofluorescence assays, 7, 8 enzymatic activity assays, metabolic flux analysis via NMR, 9 analytical ultracentrifugation 10 , and in silico modeling; 11 (ii) the second one was characterized by a deletion of amino acid residues 12-23, which resulted in the loss of affinity for the binding of deoxygenated-Hb (hereon referred to as binding site KO or BS KO) 34 (Fig.1.B) . Based on this model (Suppl. Fig.1 .A-C), here we hypothesized that HA Del and BS KO mice would store poorly, owing to the incapacity to activate the PPP as result of the lack of residues 1-11 or 12-23 of the N-terminus of AE1, respectively ( Fig.1.A-B) . Importantly, genetic ablation of AE1 N-term in these mice phenocopies the storageinduced fragmentation of AE1 N-term at multiple residues in human RBCs (Suppl. Fig.1.D) . RBCs from WT, HuB3, HA Del and BS KO mice were stored under refrigerated conditions for 12 days, prior to metabolomics and unsupervised multivariate analyses ( Fig.1.C-D, Suppl.Table1) . The latter highlighted a significant impact of genotype on the end of storage levels of metabolites involved in glycolysis, the PPP and glutathione homeostasis ( Fig.1.E; Suppl. Fig.2.A-B) . To further investigate the impact on glycolysis and the PPP, RBCs from these four mouse strains were incubated with 1,2,3-13 C 3 -glucose upon stimulation with methylene blue (MB - Figure 1 .F). MB is metabolized into leukomethylene blue in a reaction that consumes NADPH and thus promotes PPP activation by law of mass action. 31 Determination of lactate isotopologues 2,3-13 C 2 and 1,2,3-13 C 3and their ratios -are indicative of the activation of the PPP and glycolysis, respectively, since the first carbon atom of 1,2,3-13 C 3 -glucose is lost in the form of 13 

Fresh and stored RBCs from HA Del or BS KO mice also showed increased levels of carboxylic acids (succinate, fumarate, malate), acyl-carnitines (hexanoyl-, decanoyl-, dodecenoyl-, tetradecenoyl and hexadecanoyl-carnitine) and lipid peroxidation products compared to WT and HuB3 mouse RBCs, especially metabolites of the arachidonic and linoleic acid pathway Fig.1.J) .

In 2005, Perrotta and colleagues 30 identified a son of a consanguineous marriage with severe anemia, which was associated with a deficiency of AE1 expression (~10% of normal levels). Fig.4 .D-G).

A large cohort of 13,806 healthy donor volunteers was enrolled in the Recipient Epidemiology and Donor assessment Study -REDS III-RBC Omics. 32 Units from these donors were stored for up to 42 days prior to determination of the RBC susceptibility to hemolysis following osmotic insults. 37 Genome wide association studies (GWAS) of over 879,000 SNPs 36 revealed that the highly polymorphic region on chromosome 17 coding for AE1 (gene name SLC4A1) ranked amongst the top correlates to osmotic fragility in the whole study ( Fig.2 

After confirming the lack of the N-term portion of AE1 in the KO mice (Suppl. Fig.3 .E-G), we characterized the proteomes of RBCs from the four mouse strains, with a focus on protein levels that were similarly altered in both HA Del or BS KO mice, or uniquely altered in either KO (Suppl. To test the latter hypothesis, we used thermal proteome profiling (TPP) coupled to tandem mass tag 10 (TMT10 - Fig.3 .A) to determine candidate interacting partners to AE1 . Candidate interactors are identified as those with the most extreme alterations in the temperature at which their solubility decreases/increases and precipitation is observed (ΔTm - Fig.3 

To confirm and expand on the TPP-TMT10 analyses, we recombinantly expressed AE1 1-56 with a His-SUMO-tag at either the N-or C-terminus, prior to incubation with human plasma, RBC cytosols and membrane from human RBC lysates and purification/pull-down of interacting partners Suppl. Fig.5.A) . Pathway analyses of the hits from these analyses confirmed most of the hits from TPP (Suppl.Table1), revealing a widespread network of interactors of AE1, including up to 63 proteins involved in metabolic regulation, as mapped against the KEGG pathway map of human metabolism (Suppl. Fig.5 .B-C). One limitation of the TPP and immunoprecipitation approaches is that they identify both direct and indirect interactors to AE1 that can be pulled down because of their complexing with direct AE1 interactors. To disambiguate between direct and indirect interactors to AE1 1-56 , we repeated the precipitation experiments by also introducing cross-linking To further focus on the AE1 N-term, crosslinking proteomics studies were repeated by adding recombinant AE1 1-56 . This approach afforded determination of direct AE1 1-56 protein interactors by identifying cross-linked free epsilon-amines of K with adjacent identical residues (DSSO) or carbon atoms in the carboxylic groups of D or E amino acids (DMTMM - Fig.4 

provided these residues face each other within a range spanning from 11.4 to 24 Å. 45 The list lower scores than the cross-links with HBB). 5 In addition, direct cross-links were identified for AE1 1-56 with spectrin beta (SPTB1 -residues 23 to 1664, respectively), ankyrin (residue 10 -381 - 

The interaction between recombinant GAPDH tetramers ( Fig.6 .A) and Table 1 ). Cross-linked residues are mapped against GAPDH monomeric structure in Fig.6 .H. Similar results were obtained when probing interactions between GAPDH and AE1 1-30 (Suppl. Fig.8 .C-E), with the exception of cross-links between E40, a hot spot for interaction with several GAPDH residues in the longer AE1 peptide (3, 5, 84, 86, 194, 219, 251, 259, 260, 263 -Fig.6.G) . These experiments provide further proof of a direct interaction of the N-terminus of AE1 to GAPDH and indicate that the N-terminal region comprising residues 1-20 is the primary binding site with additional contacts that also contribute to the AE1/GAPDH interaction. ITC, NMR and cross-linking proteomics data were used to build a model of AE1 1-56 interaction with GAPDH with the software Rosetta, resulting in the active site pocket of GAPDH being exposed to residues 1-15 of AE1 (Fig.6 .I-K; distances between K and D/E residues are shown in Suppl. Fig.8.F) .

To rescue the genetic defect resulting from ablation of the AE1 N-term, we designed three membrane permeable versions 48 of AE1 1-56 through addition of a polyarginine (polyArg), internalization sequence or TAT sequence at the C-term of the peptide (Fig.7.A) . Human RBCs were thus incubated with a control (scramble), an AE1 1-56 peptide (non-penetrating) or the three penetrating peptides in presence of 1,2,3-13 C 3 -glucose and methylene blue stimulation to activate the PPP (Fig.7.A) . Tracing experiments show that PPP activated following MB in all cases, but ATP synthesis was only preserved in the RBCs treated with the cell penetrating peptides (Fig.7.B) , consistent with the schematic in Fig.7 .C. We thus hypothesized that incubation with polyArg-AE1 1-56 would at least partially rescue the defect in PPP activation upon MB stimulation of RBCs from AE1 KO mice, especially HA Del (Fig.7 .D). Results show increased glutathione oxidation (GSSG/GSH ratios) in response to MB treatment in all cases, but significant rescue by the AE1 peptide in both AE1 KOs. Storage of murine RBCs from the four mouse strains in presence of polyArg-AE1 1-56 promoted increases in PTR in WT and HA Del mice back to levels observed in

HuB3, but not in BS KO mice (Fig.7 .E).

Here we provide the first direct mechanistic evidence of a role for the N-term of AE1 in regulating RBC storage quality. Using multiple state of the art direct and indirect structural approaches, we provide the first experimental overview of the RBC interactome, with a focus on the N-term of band 3. While The structure of the N-terminus of AE1 beyond residue K56 has been solved through crystallography 49 To this end, in this study we leveraged humanized AE1 mice 12 , and compared them to WT mice (C57BL6), or humanized mice lacking residues 1-11 (deletion of the high affinity binding region for glycolytic enzyme, as previously suggested by immunofluorescence studies 12 -HA Del) or 12-23 (hemoglobin binding site -BS KO) mice -B). RBCs from these mice were stored under refrigerated conditions for 12 days, prior to metabolomics analyses (C). Storage and genotypes had a significant impact on RBC metabolism, as gleaned by unsupervised principal component analysis (D) and hierarchical clustering analysis of significant metabolites by ANOVA (E). Specifically, strain-specific differences were noted in fresh and stored RBCs in glycolysis, pentose phosphate pathway (PPP) and glutathione homeostasis. To further investigate the impact on glycolysis and the PPP, RBCs from these four mouse strains were incubated with 1,2,3-13 C 3 -glucose upon stimulation with methylene blue (MB). Rescue experiments were also performed by incubating RBCs with a recombinantly expressed N-term AE1 peptide (residues 1-56 -F), prior to determination of the ratios of lactate isotopologues +3 and +2, deriving from glycolysis and the PPP, respectively (G-H). (ΔTm -B) . A few representative melting curves for the top hits for proteins stabilized or destabilized by the presence of the band 3 peptide 1-56 (red) compared to untreated controls (blue) is provided in C. A peptide coding for the amino acids 1-56 of the N-term of band 3 was recombinantly expressed with a SUMO-tag and/or a His-Flag tag at either the N-or C-term terminus of the peptide, prior to incubation with plasma, red blood cell cytosols and membrane in independent experiments, enrichment in Nichel columns, pull-down against the SUMO tag, and cross-linking with agents disuccinimidyl sulfoxide (DSSO) or 4-(4,6-dimetoxy-1,3,5-triazin-2-yl)-4metylmorpholinium -DMTMM), prior to protein digestion, fractionation of cross-linked peptides and nanoUHPLC-MS/MS-based identification of band 3 interacting partners via MS2/MS3 analyses (D). Top interactors for RBC membrane and cytosol interactors are listed in E-F, respectively, divided by pathway.

Focus on the interactome of AE1 1-56. . In A, an overview of the cross-linking strategy with DSSO. This approach affords determination of protein-protein interactions by cross-linking free amines of adjacent residues of interacting proteins within a range spanning from 11.4 to 24 Å. In the present study, DSSO and DMTMM (E/D residues to K) were combined to investigate the RBC interactome (B). In C, circos plot view of the protein-protein cross-links identified in this study (full list in Supplementary Table 1 ). In D, the same inputs were used to provide a network view of the results. In E, an interactomics overview merging the data from all the cross-linking proteomics studies, showing direct and indirect interactors with band 3 1-56 and the residues on band 3 with which the proteins were identified to cross-link to. 

GAPDH was recombinantly expressed in E.coli prior to purification and interaction studies with the recombinantly expressed band 3 peptide (residues 1-56 -A) . These studies included isothermal titration calorimetry (B), nucelar magnetic resonance of band 3 (1-56) with 100 or 200 uM GAPDH (C) and derived calculation of chemical shift perturbations (CSP -D), in silico modeling of band 3 (1-56) structure based on NMR data (E). Following these studies, cross-linking proteomics analyses were performed in vitro by co-incubating GAPDH and band 3 (1-56) in presence of DSSO or DMTMM. In F, a representative spectrum from one of the most abundant cross-links, which are comprehensively mapped in the circos plot (light blue for intramolecular cross-links, red for intermolecular ones) in G. Results were thus mapped against GAPDH monomeric structure in H (blue: all lysine residue on GAPDH that were experimentally found to cross-link to band 3 aspartyl or glutamyl side chains, vs in yellow the lysine that were available for crosslinking but were not found to face band 3 acidic residues within the reach of the crosslinker of ~20 Å). In H-J-K, NMR and cross-linking proteomics data were used to build a model of band 3 (1-56) interaction with GAPDH with the software Rosetta, resulting in the active site pocket of GAPDH being exposed to residues 1-15 of band 3. To this end, in this study we leveraged humanized AE1 mice 1 , and compared them to WT mice (C57BL6), or humanized mice lacking residues 1-11 (deletion of the high affinity binding region for glycolytic enzyme, as previously suggested by immunofluorescence studies 1 -HA Del) or 12-23 (hemoglobin binding site -BS KO) mice -B). RBCs from these mice were stored under refrigerated conditions for 12 days, prior to metabolomics analyses (C). Storage and genotypes had a significant impact on RBC metabolism, as gleaned by unsupervised principal component analysis (D) and hierarchical clustering analysis of significant metabolites by ANOVA (E). Specifically, strain-specific differences were noted in fresh and stored RBCs in glycolysis, pentose phosphate pathway (PPP) and glutathione homeostasis. To further investigate the impact on glycolysis and the PPP, RBCs from these four mouse strains were incubated with 1,2,3-13 C3-glucose upon stimulation with methylene blue (MB). Rescue experiments were also performed by incubating RBCs with a recombinantly expressed N-term AE1 peptide (residues 1-56 -F), prior to determination of the ratios of lactate isotopologues +3 and +2, deriving from glycolysis and the PPP, respectively ( (ΔTm -B) . A few representative melting curves for the top hits for proteins stabilized or destabilized by the presence of the band 3 peptide 1-56 (red) compared to untreated controls (blue) is provided in C. A peptide coding for the amino acids 1-56 of the N-term of band 3 was recombinantly expressed with a SUMO-tag and/or a His-Flag tag at either the N-or C-term terminus of the peptide, prior to incubation with plasma, red blood cell cytosols and membrane in independent experiments, enrichment in Nichel columns, pull-down against the SUMO tag, and cross-linking with agents disuccinimidyl sulfoxide (DSSO) or 4-(4,6-dimetoxy-1,3,5-triazin-2-yl)-4-metylmorpholinium -DMTMM), prior to protein digestion, fractionation of cross-linked peptides and nanoUHPLC-MS/MS-based identification of band 3 interacting partners via MS2/MS3 analyses (D). Top interactors for RBC membrane and cytosol interactors are listed in E-F, respectively, divided by pathway.

Figure 4 -Experimental RBC interactome, as gleaned by cross-linking mass spectrometry. Focus on the interactome of AE11-56. . In A, an overview of the cross-linking strategy with DSSO. This approach affords determination of protein-protein interactions by cross-linking free amines of adjacent residues of interacting proteins within a range spanning from 11.4 to 24 Å. In the present study, DSSO and DMTMM (E/D residues to K) were combined to investigate the RBC interactome (B). In C, circos plot view of the protein-protein cross-links identified in this study (full list in Supplementary Table 1 ). In D, the same inputs were used to provide a network view of the results. In E, an interactomics overview merging the data from all the cross-linking proteomics studies, showing direct and indirect interactors with band 3 1-56 and the residues on band 3 with which the proteins were identified to cross-link to. 1-56) . GAPDH was recombinantly expressed in E.coli prior to purification and interaction studies with the recombinantly expressed band 3 peptide (residues 1-56 -A). These studies included isothermal titration calorimetry (B), nucelar magnetic resonance of band 3 (1-56) with 100 or 200 uM GAPDH (C) and derived calculation of chemical shift perturbations (CSP -D), in silico modeling of band 3 (1-56) structure based on NMR data (E). Following these studies, cross-linking proteomics analyses were performed in vitro by co-incubating GAPDH and band 3 (1-56) in presence of DSSO or DMTMM. In F, a representative spectrum from one of the most abundant cross-links, which are comprehensively mapped in the circos plot (light blue for intramolecular cross-links, red for intermolecular ones) in G. Results were thus mapped against GAPDH monomeric structure in H (blue: all lysine residue on GAPDH that were experimentally found to cross-link to band 3 aspartyl or glutamyl side chains, vs in yellow the lysine that were available for crosslinking but were not found to face band 3 acidic residues within the reach of the crosslinker of ~20 Å). In H-J-K, NMR and cross-linking proteomics data were used to build a model of band 3 (1-56) interaction with GAPDH with the software Rosetta, resulting in the active site pocket of GAPDH being exposed to residues 1-15 of band 3. Three membrane permeable versions of the band 3 (1-56) peptide were generated through addition of a poly arginine (polyArg), internalization sequence or TAT sequence at the C-term of the peptide. Human RBCs were thus incubated with a control (scramble), a band 3 1-56 peptide (non-penetrating) or the three penetrating peptides in presence of 1,2,3-13 C3-glucose and methylene blue stimulation to activate the pentose phosphate pathway (A). In B, 13C isotopologues of glycolysis and pentose phosphate pathway are reported for all groups at baseline and following methylene blue stimulation of healthy human RBCs, showing increases in PPP activation following MB in all cases, even though ATP levels were only preserved in the RBCs treated with the cell penetrating peptides, suggesting a metabolic reprogramming consistent with the schematic in C. In D, RBCs from WT, humanized band 3 (HuB3) or band 3 KO mice lacking residues 1-11 (HA Del) or 12-23 (BS KO) were stimulated with MB in presence of a cell penetrating version of the band 3 peptide (polyArg). Results show increased glutathione oxidation in response to MB treatment in all cases, but significant rescue by the band 3 peptide, especially in the HA Del and BS KO groups. Similarly, storage of murine RBCs from the WT and band 3 KO mouse strains in presence of the polyArg cell penetrating band 3 1-56 peptide promoted increases in post-transfusion recoveries in WT and HA Del mice, but not in BS KO mice (E).

proteomics studies with recombinantly expressed band 3 1-56. A peptide coding for the amino acids 1-56 of the N-term of band 3 was recombinantly expressed with a SUMO-tag at either the N-or C-term terminus of the peptide, prior to incubation with plasma, red blood cell cytosols and membrane in independent experiments, pull-down against the SUMO tag, fractionation and nanoUHPLC-MS/MS-based identification of band 3 interacting partners (A). Pathway analyses of the hits from this analysis revealed a widespread interaction of band 3 with up to 63 proteins involved in metabolic regulation, as mapped against the KEGG pathway map of human metabolism (B). In C, enzymes identified from the pull down of SUMO-tagged band 3 1-56 mapped against the Metabolic pathways map (KEGG map: hsa01100).

that have weaker interaction than AE1 1-56 (44.8 uM vs 2.56 uM). Cross-links with DMTMM are listed in C and DSSO cross-links on GAPDH with D/E on band 3 1-30 were mapped against GAPDH structure in D-E. In F, distance of cross-linked lysine (K -green) ɛ-amine side chain residues on glyceraldehyde 3-phosphate dehydrogenase and carboxylic acid side chains of glutamate/aspartate carboxylate residues on band 3 (residues 1-56 -no K is present on band 3 before residue 57) as experimentally determined by DSSO cross-linking proteomics.

Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk

Red blood cell storage lesion: causes and potential clinical consequences

Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion

Quantitative Analysis of Human Red Blood Cell Proteome

Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties

Interaction of deoxyhemoglobin with the cytoplasmic domain of murine erythrocyte band 3

Identification of the components of a glycolytic enzyme metabolon on the human red blood cell membrane

Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia

Role of band 3 in regulating metabolic flux of red blood cells

The complex of band 3 protein of the human erythrocyte membrane and glyceraldehyde-3-phosphate dehydrogenase: stoichiometry and competition by aldolase

Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase

Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3

Oxygen-linked modulation of erythrocyte metabolism: state of the art

Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance

Protect, repair, destroy or sacrifice: a role of oxidative stress biology in inter-donor variability of blood storage?

AltitudeOmics: Red Blood Cell Metabolic Adaptation to High Altitude Hypoxia

Human erythrocyte metabolism is modulated by the O2-linked transition of hemoglobin

Changes in hexokinase, aldolase, glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase and glutamic-oxalacetic transaminase

The role of hemoglobin denaturation and band 3 clustering in red blood cell aging

Oxidative stress and caspase-mediated fragmentation of cytoplasmic domain of erythrocyte band 3 during blood storage

Time-course investigation of SAGM-stored leukocytefiltered red bood cell concentrates: from metabolism to proteomics

Methylation of protein aspartates and deamidated asparagines as a function of blood bank storage and oxidative stress in human red blood cells. Transfusion

Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells

Proteomics of Stored Red Blood Cell Membrane and Storage-Induced Microvesicles Reveals the Association of Flotillin-2 With Band 3 Complexes

Blood bank conditions and RBCs: the progressive loss of metabolic modulation

Glucose 6-phosphate dehydrogenase deficient subjects may be better "storers" than donors of red blood cells

Transition to 37 degrees C reveals importance of NADPH in mitigating oxidative stress in stored RBCs

Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate metabolic reprogramming of stored red blood cells

Band 3 phosphorylation induces irreversible alterations of stored red blood cells

The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function

Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion

Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity

Changes in Band 3 oligomeric state precede cell membrane phospholipid loss during blood bank storage of red blood cells

Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties

Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice

Development and evaluation of a transfusion medicine genome wide genotyping array

Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study

Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells

High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods

Untargeted and Semi-targeted Lipid Analysis of Biological Samples Using Mass Spectrometry-Based Metabolomics

Red blood cell proteomics update: is there more to discover?

Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

Annotating N termini for the human proteome project: N termini and Nalpha-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome

The red blood cell proteome and interactome: an update

CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative splicing

A spectrin membrane skeleton of the Golgi complex

Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3

Internalization mechanisms of cell-penetrating peptides

Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3

The role of extracellular histone in organ injury

Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients

Supplementary Figure 1 -A schematic model of the band 3-dependent regulation of glycolysis and the pentose phosphate pathway, as proposed by Low's, Castagnola's, Xia's and Doctor's groups. At low oxygen saturation, deoxyhemoglobin binds to the N-term of band 3, while glycolytic enzymes are displaced from the same region and are active -resulting in increased fluxes through glycolysis and decreased fluxes through the pentose phospahte pathway (A). At high oxygen saturation, hemoglobin is displaced from the membrane and glycolytic enzymes bind to the N-term of band 3, resulting in their partial inhibition, decreases in fluxes through glycolysis and increased fluxes through the pentose phosphate pathway to generate the reducing equivalent NADPH necessary to counteract oxidant stress, which in turn increases as a function of Fenton chemistry in presence of oxygen (B). In C, in light of this model and the existing literature from our group and others, we predict that RBCs from mice lacking the N-term of band 3 would suffer from increased oxidant stress during storage under refrigerated conditions. We anticipate that RBCs from these mice would de facto phenocopy G6PD deficiency owing to the incapacity to redirect glucose oxidation fluxes towards the pentose phosphate pathway (C). In D, Re-elaboration of TAILS data from Lange et al. showing N-term band 3 residues that are fragmented at the end of the shelf-life of human packed red blood cells (storage day 42).

Analyses of fresh and stored RBCs from wild type (C57BL6), humanized band 3 mice (HuB3) and mice lacking amino acids 1-11 (HA Del) or 12-23 (BS KO) of band 3 showed strain-specific differences in fresh and stored RBCs in glycolysis (A), pentose phosphate pathway (PPP) and glutathione homeostasis (B). Data in panels A-B report fold-change measurements in HA Del and BS KO mice normalized to the humanized band 3 mice (HuB3). To further investigate the impact on glycolysis and the PPP, RBCs from these four mouse strains were incubated with 1,2,3-13C3-glucose upon stimulation with methylene blue (MB). Rescue experiments were also performed by incubating RBCs with a recombinantly expressed N-term AE1 peptide (residues 1-57 -C), prior to determination of lactate isotopologues +3 and +2, deriving from glycolysis and the PPP, respectively (C). Metabolomics analyses of stored RBCs from the four strains also showed that RBCs from band 3 KO mice had increased levels of carboxylic acid and lipid peroxidation (D), especially metabolites of the arachidonate metabolism (E), including prostaglandins, eicosanoids, hydroxyeicosatetraenoates and octadecenoate (HETEs and HODes -F). Metabolomics analyses on fresh and stored RBCs from 13 different mouse strains (G) highlight these metabolites as significant correlates to poor posttransfusion recoveries (H), as highlighted by the metabolite set enrichment analysis in I and the ranked top positive and negative correlates to PTR reported in 

Metabolomics and proteomics analyses were performed on RBCs from a male subject suffering from a genetic mutation resulting in the deletion of the first 11 amino acids of band 3, de facto phenocopying the high affinity deletion KO mice investigated in this study (A). Results highlight a significant alteration of glycolysis (increase), glutathione homeostasis (increased oxidant stress) and polyamine metabolism in this subject compared to healthy controls (n=3 -B) . Proteomics analyses showed higher levels of hexokinase, but lower levels of all the remaining glycolytic enzymes downstream to it, as well as of enzymes of the pentose phosphate pathway and glutathione synthesis in the RBCs from the band 3 Neapolis individual (C). Tracing experiments with stable heavy isotope-labeled tracers ( 13 C 15 N-glutamine -D; 13 C-citrate -E, 13 C 15 N-methionine -F, and deuterium labeled-arachidonate -G) confirmed alterations of glutaminolysis, carboxylic acid metabolism, isoaspartyl-damage repair via methylation and oxylipin metabolism (I) in the RBCs from the band 3 Neapolis subject -suggesting a role for band 3dependent regulation of RBC metabolism beyond glycolysis and the pentose phosphate pathway. Specifically, increased consumption of labeled glutamine and generation of labeled glutamate, accompanied by decreases in labeled alphaketoglutarate and alanine are consistent with increased glutaminase activity and decreased transamination in RBCs from the band 3 Neapolis subject compared to controls (D). No significant differences were observed with respect to the levels of labeled citrate, or citratederived alpha-ketoglutarate (E). However, band 3 Neapolis RBCs had four-fold higher levels 13 C4succinate and malate, in part explained by the higher degree of reticulocytosis in this subject (0.35x106/μl -Supplementary Table 1 ). None of the defects mentioned above was aggravated by treatment with MB or rescue with the recombinant AE11-56 peptide. Studies with labeled methionine showed significant methionine oxidation into its sulfoxide form, especially in response to MB, a defect that was normalized to control values following rescue with the AE11-56 peptide (F). Increased arachidonate metabolism in tracing experiments with deuterium-labeled arachidonic acid (G), consistent with what observed in band 3 KO mice.Supplementary Figure 6 -Cross-linking proteomics studies recapitulate structural elucidation of hemoglobin tetramers. In A, bar plots show the experimental intra (purple) or inter-molecular crosslinks (teal) between alpha and beta hemoglobin chains (HBA and HBB), respectively. Based on these experimental data, cross-links were mapped against the structure of hemoglobin tetramers for human oxyhemoglobin (6BB5.pdb -B) . In C, highlighted crosslinks and distances between K18 of HBA and neighboring residues. In D, a representative mass spectrum from MS3 analyses of one of the highestscores cross-links, between the peptides containing K12 and E122 of HBA and HBB, respectively (y and b series ions are annotated). In E and F, matrix plots showing cross-links between HBA and HBB (teal) or within HBB (purple for intra and teal for inter-chain cross-links).

These interactions are shown in bar plot format for band 3 (B3AT) with several hemoglobin chains (including alpha, beta, delta and epsilon -HBA, HBB, HBD and HBE -A), with a zoom on the cross-links between B3AT and HBB in B. In C and D, the interactions in B are highlighted against hemoglobin structure and B3AT cytosolic regions 1-15 and 56-356.